文献速递腹部技术与安全MR

基于深度学习的多期动脉期MRI在肝细胞癌中的临床应用价值

Clinical Utility of Deep Learning-based Multiple Arterial Phase MRI in Hepatocellular Carcinoma.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

这项前瞻性研究纳入疑似肝细胞癌患者,比较基于深度学习的超快多期动脉期MRI与常规单期动脉期MRI在细胞外对比剂和肝胆对比剂增强下的表现。多期动脉期MRI提高了晚期动脉期捕获率、图像质量及病灶、动脉期高强化和肝细胞癌检出率,并在单次扫描中实现可靠的肝动脉显示。

要点

  • 多期动脉期MRI较单期提高晚期动脉期捕获率:细胞外对比剂组98% vs 81%,肝胆对比剂组98% vs 85%。
  • 多期动脉期MRI提高肝细胞癌检出率:细胞外对比剂组96% vs 81%;肝胆对比剂组病灶检出97% vs 88%、动脉期高强化97% vs 86%。
  • 多期成像在两种对比剂下肝动脉显示均获满意评分(四项Likert量表各类别平均分>3)。

核心结论

  • 基于深度学习的超快多期动脉期MRI改善了晚期动脉期捕获、图像质量和肝细胞癌诊断,并在与细胞外对比剂和肝胆对比剂兼容的单次扫描中实现可靠的肝动脉显示。

研究设计与样本

  • 前瞻性研究,纳入2024年9月至2025年3月间疑似肝细胞癌并接受细胞外对比剂或肝胆对比剂增强MRI的参与者。

关键影像表现/征象

  • 细胞外对比剂组多期MRI较单期提高晚期动脉期捕获率(98% vs 81%,P=.001)。
  • 细胞外对比剂组多期MRI总体图像质量(P=.03)、运动伪影(P<.001)、病灶边缘锐利度(P<.001)和病灶可见度(P=.007)评分更高。
  • 肝胆对比剂组多期MRI较单期提高晚期动脉期捕获率(98% vs 85%,P=.04)。
  • 肝胆对比剂组多期MRI总体图像质量(P=.01)、运动伪影(P=.04)和病灶边缘锐利度(P=.005)评分更高。
  • 多期成像在两种对比剂组肝动脉显示均获满意评分(四项Likert量表各类别平均分>3)。

诊断标准与关键数值

  • 细胞外对比剂组多期MRI较单期提高病灶检出率(98% vs 90%,P=.01)、动脉期高强化检出率(96% vs 88%,P=.03)和肝细胞癌检出率(96% vs 81%,P<.001)。
  • 肝胆对比剂组多期MRI较单期提高病灶检出率(97% vs 88%,P=.04)和动脉期高强化检出率(97% vs 86%,P=.02)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the clinical utility of deep learning-based ultrafast multiple arterial phase (AP) MRI for diagnosing hepatocellular carcinoma (HCC), compared with conventional single AP imaging, using both extracellular agents (ECAs) and hepatobiliary agents (HBAs). Materials and Methods This prospective study included participants with suspected HCC who underwent either ECA- or HBA-enhanced MRI between September 2024 and March 2025. Outcomes included late AP capture rate, image quality (overall quality, motion artifacts, noise, liver and lesion edge sharpness, and lesion conspicuity), diagnostic performance (lesion, arterial phase hyperenhancement [APHE], and HCC detection rates), and hepatic arterial visualization scoring. Wilcoxon rank sum, Pearson χ2, and Fisher exact tests compared characteristics from multiple and single AP MRI. Results The final analysis included 128 participants who underwent ECA-enhanced MRI (64 multiphase, 64 single-phase; median age, 61 years [IQR, 54-69 years]; 103 male) and 108 participants who underwent HBA-enhanced MRI (54 multiphase, 54 single-phase; median age, 62 years [IQR, 56-69 years]; 83 male). In the ECA group, multiple AP MRI resulted in greater late AP capture (98% vs 81%; P = .001); higher scores for overall image quality (P = .03), motion artifacts (P < .001), lesion edge sharpness (P < .001), and lesion conspicuity (P = .007); and higher lesion (98% vs 90%; P = .01), APHE (96% vs 88%; P = .03), and HCC (96% vs 81%; P < .001) detection rates. In the HBA group, multiple AP MRI examinations also resulted in greater late AP capture (98% vs 85%; P = .04); higher scores for overall image quality (P = .01), motion artifacts (P = .04), and lesion edge sharpness (P = .005); and higher lesion (97% vs 88%; P = .04) and APHE (97% vs 86%; P = .02) detection rates. Multiphase imaging consistently achieved satisfactory hepatic arterial visualization in both contrast agent groups (mean scores > 3 on a four-point Likert scale for all categories). Conclusion Deep learning-based ultrafast multiphase arterial MRI improved late AP capture, image quality, and HCC diagnosis and enabled reliable hepatic arterial visualization within a single scan compatible with ECA and HBA. Keywords: MR-Imaging, Abdomen/GI, Liver Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Liu K, Zheng B, Zhang Y, et al. Clinical Utility of Deep Learning-based Multiple Arterial Phase MRI in Hepatocellular Carcinoma. Radiol Imaging Cancer. 2026. PMID: 41860367. doi:10.1148/rycan.250538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。